Recently two germline mutations in the oligomerization domain of p53 have been identi®ed in patients with Li ± Fraumeni and Li ± Fraumeni-like Syndromes. We have used biophysical and biochemical methods to characterize these two mutants in order to better understand their functional defects and the role of the p53 oligomerization domain (residues 325 ± 355) in oncogenesis. We ®nd that residues 310 ± 360 of the L344P mutant are monomeric, apparently unfolded and cannot interact with wild-type (WT) p53. The full length L344P protein is unable to bind sequence speci®cally to DNA and is therefore an inactive, but not a dominant negative mutant. R337C, on the other hand, can form dimers and tetramers, can hetero-oligomerize with WTp53 and can bind to a p53 consensus element. However, the thermal stability of R337C is much lower than that of WTp53 and at physiological temperatures more than half of this mutant is less than tetrameric. Thus, the R337C mutant retains some functional activity yet leads to a predisposition to cancer, suggesting that even partial inactivation of p53 oligomerization is sucient for accelerated tumour progression.
Wild-type p53 (WTp53) is a nuclear phosphoprotein that functions as a tumour suppressor. Inactivation of p53 through either deletion, mutation or interaction with cellular or viral proteins is a key step in over half of all human cancers (reviewed in Donehower and Bradley, 1993; Ko and Prives, 1996; Levine, 1997) . The primary function of p53 in normal cells appears to be the induction of growth arrest or apoptosis in response DNA damage through its role as a transcriptional activator of genes involved in the regulation of the cell cycle (El-Deiry et al., 1993; Harper et al, 19923; Kastan et al., 1992; Xiong et al., 1993) and apoptosis (Miyashita and Reed, 1995; Polyak et al., 1997) . Like many transcription factors, p53 is a modular protein containing an N-terminal activation domain, a central DNA-binding domain, a tetramerization domain (tet domain) and a C-terminal regulatory domain (reviewed in Ko and Prives, 1996; Levine, 1997) . Almost all tumour-derived p53 mutations tested so far are de®cient in sequence speci®c DNA-binding, with the vast majority of missense mutations residing in the DNA-binding domain (Cariello et al., 1994; Hollstein et al., 1991) . Relatively few tumour-derived mutations have been reported for the tet domain (Cariello, 1994) suggesting that either it is more tolerant of mutations than the core domain (Ishioka et al., 1995; Jerey et al., 1995; Waterman et al., 1995) , or that tetramerization is not necessary for tumour suppressor function (Ishioka et al., 1997; Tarunina and Jenkins, 1993) . However, the fact that germline mutations in the tet domain have recently been documented for two families with Li ± Fraumeni and Li ± Fraumeni-like syndromes (inherited susceptibility to certain cancers associated with a germline mutation in p53) support a role for the tet domain in tumour suppression (Lomax et al., 1997; Varley et al., 1996) . Indeed, Lomax et al. (1997) suggest that the paucity of mutations in the Cterminal (and N-terminal) domains of p53 may be exaggerated by the fact that many researchers do not sequence these regions of the gene when looking for tumour-related or germline mutations. We report here the biophysical and biochemical characterization of these two Li ± Fraumeni mutations in the tet domain. These data suggest that even partial destabilization of the tet domain can lead to a functionally defective protein which may account for the phenotype of these mutations. Figure 1 shows the sites of the two mutations within the three-dimensional structure of the tet domain (Lee et al., 1994) . The tet domain is a dimer of dimers. Each dimer contains an antiparallel b-sheet packed against a pair of antiparallel a-helices. Two dimers interact through a large hydrophobic surface on each helix pair to form a 4-helix bundle sandwiched between two pairs of b-sheets. One dimer is rotated relative to the other so that they cross one another in a roughly orthogonal manner (Figure 1 ). Mutation of Leu344 to Pro (L344P; Varley et al., 1996) in the center of the ahelix of each subunit would be expected to severely disrupt the structure of the helix. Mutation of Arg337 to Cys (R337C; Lomax et al., 1997) removes a salt bridge and hydrophobic interactions between opposite subunits of each dimer. In order to better understand the eects these mutations have on the structure and function of p53 we expressed and puri®ed recombinant WTp53, L344P and R337C as well as C-terminal constructs containing the oligomerization domain of each protein. Because the tet domain is known to be the primary determinant of p53 oligomerization (Pavletich et al., 1993; Wang et al., 1994; Waterman et al., 1995) , the oligomeric state of p53 constructs that contain the tet domain should accurately re¯ect the oligomeric state of the intact protein.
We used circular dichroism (CD) spectroscopy to assess the amount of secondary structure present in each mutant, relative to WTp53 (Figure 2 ). R337C(311 ± 360) has a similar CD spectrum compared with WTp53(311 ± 360), but with slightly less ellipticity at 222 nm indicating that the mutant has less a-helix content on average at ambient temperature. L344P(311 ± 360) has a very dierent trace from both WTp53 and R337C with a much weaker signal at 222 nm. The CD signal is also a convenient tool for comparing the thermal stability of the mutants with WTp53. When the CD intensity at 222 nm is followed as a function of temperature we ®nd that R337C(311 ± 360) unfolds at a much lower temperature than WTp53(310 ± 360) (Figure 2b) . Interestingly, the melting temperature (temperature at which 50% of the protein is unfolded) is 338C for R337C compared to 858C for WTp53. For L344P the intensity at 222 nm does not change signi®cantly with temperature indicating that there is very little secondary structure present in this mutant at any temperature. Figure 3 shows an SDS polyacrylamide gel of mutant and WTp53 C-terminal constructs containing the tet domain. Glutaraldehyde crosslinking of these proteins at 48C, 218C and 378C shows that both WT (lanes 1 ± 4) and R337C (lanes 6 ± 9) tet domains form dimers, trimers and tetramers, but L344P (10 ± 13) does not oligomerize. The apparent higher degree of crosslinking of R337C compared to WTp53 can be explained by the fact that the R337C construct has an additional 33 residues including several lysines and therefore has more sites that are chemically reactive with glutaraldehyde. However, comparison of the distribution of oligomeric species for WTp53 and R337C with increasing temperature reveals a significant dierence between the two proteins. At 48C both proteins crosslink to similar oligomeric states (dimer and some trimer) even though R337C should be more reactive to the crosslinking agent if the two proteins had equivalent oligomeric states. At 218C R337C has a higher proportion of tetramers than WTp53 indicating that the mutant can form tetramers at this temperature. Finally, at 378C WTp53 has a higher proportion of oligomers compared to lower temperature, but R337C has a lower proportion of oligomers. These , 1994) . The polypeptide backbone of residues 325 ± 355 is displayed as a ribbon, with each subunit shaded dierently. The sidechains of Arg337 and Leu344 are displayed as ball-and-stick models. Mutation of Leu344 to Pro should disrupt each helix, while the mutation of Arg337 to Cys removes four stabilizing, intra-dimer salt bridges with D352. PCR directed mutagenesis was used to generate L344P and R337C mutants of full length p53 in the pET15b expression vector (Novagen Inc.; Studier et al., 1991) . C-terminal constructs of all three proteins were also subcloned into pET15b and the (His) 6 -tagged fusion proteins were expressed in E. coli BL21(DE3) harboring pLysS. C-terminal constructs were expressed and puri®ed by Ni 2+ anity chromatography as described in Lee et al. (1994) except that the (His) 6 anity tag was not removed resulting in an extra 17 amino acids at the N-terminus of each protein unless noted otherwise. Full length protein was expressed and puri®ed as described in Vaziri et al. (1997) 
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Figure 2 (a) Circular dichroism (CD) spectra of residues 311 ± 360 of recombinant WTp53 (*), R337C (&) and L344P (~). The presence of alpha-helical content (minimum at 222 nm) is observed for both WTp53 and R337C, while the L344P spectra is indicative of an unstructured protein. Spectra were collected at 258C at protein concentrations of 50 mM using an Aviv 62A DS CD spectrometer. Data could not be acquired for R337C below 219 nm due to scattering from the presence of 5 mM DTT in the buer which was needed to prevent oxidation. (b) Temperature dependence of the a-helical signal (222 nm) for WTp53 (*) and R337C (&) . The data is plotted as fraction unfolded assuming each protein is fully folded at 48C and completely unfolded when there is no further change in CD signal with increasing temperature data taken together with the CD results discussed above demonstrate that the equilibrium between oligomeric species is shifted toward the monomeric (and presumably unfolded) state for R337C compared to WTp53 at physiological temperatures.
A similar conclusion is reached using multi-angle laser light scattering to determine the apparent molecular weight of proteins eluting from a Pharmacia Superose 12 gel ®ltration column (data not shown). L344P(311 ± 360) eluted as single peak with an apparent molecular weight of a monomer. R337C(311 ± 393) eluted as a broad peak with molecular weights from 20 ± 30 kDa, suggesting a dimeric species (23.5 kDa). However such a broad peak is not consistent with R337C being a discrete dimeric species. An explanation more in keeping with our other biophysical results is that R337C(311 ± 393) elutes as an equilibrium mixture of monomers, dimers and tetramers resulting in a broad peak centered about the molecular weight of a dimer.
As a third method of assessing the structural defects in these mutants we acquired two-dimensional 15 N-HSQC nuclear magnetic resonance (NMR) spectra of uniformly 15 N-labelled tet domains of each protein. This type of NMR spectrum gives a`®ngerprint' characteristic of the protein sequence and threedimensional structure of the protein and is very sensitive to even small conformational changes (Clore and Gronenborn, 1991) . Figure 4 shows a comparison of the HSQC spectra of the tet domain of WTp53, R337C and L344P. WTp53 has all the hallmarks of a folded globular protein in a single stable conformation: a series of peaks of roughly uniform intensity spread out over a range of frequencies (expressed in parts per million, ppm, relative to the magnetic ®eld strength) in the 1 H dimension. The HSQC spectrum of L344P, on Figure 3 Temperature dependent glutaraldehyde cross-linking of recombinant p53 tet domain constructs. Lanes 1 ± 4: WTp53(310 ± 360); lanes 6 ± 9: R337C(311 ± 393); lanes 10 ± 13: L344P(311 ± 360) without the (His) 6 -tag. It was necessary to us the longer construct for R337C because of limited solubility of its smaller construct, especially at elevated temperatures. Each protein (50 mM) was incubated with 0% (lanes 1, 6 and 10) or 0.1% v/v (lanes 2 ± 4, 7 ± 9, 11 ± 13) glutaraldehyde for 2 h at 48C (lanes 2, 7, 11), 30 min at 258C (lanes 3, 8, 12) or 15 min at 378C (lanes 4, 9, 13). 20 ml aliquots of each reaction mixture were then run on a 15% SDS-polyacrylamide gel and stained with Coumassie Blue Figure 4 Two-dimensional 15 N-HSQC NMR spectra of uniformly 15 N-labelled oligomerization domains of WTp53 (2 mM protein in 25 mM phosphate pH 7.0, 150 mM NaCl, 0.02% NaN 3 : spectra collected for 1 h at 45 degrees), L344P (0.5 mM protein in 25 mM phosphate pH 7.0, 150 mM NaCl, 0.02% NaN 3 : spectra collected for 4 h at 258C), and R337C (0.5 mM protein in 25 mM phosphate pH 7.0, 150 mM NaCl, 5 mM DTT, 0.02% NaN 3 : spectra collected for 4 h at 25 degrees). Data was collected on a Varian Unity+500 MHz spectrometer and processed with NMRpipe software (Delaglio et al., 1995) .
15 N resonance frequency is expressed in ppm along the ordinate and the 1 H frequency of 15 N-bound hydrogens is plotted along the abscissa. Each crosspeak corresponds to either a backbone amide 15 N-H pair (the majority of peaks) or a sidechain 15 N-H group. The positions and intensities of the crosspeaks re¯ect the threedimensional structure of the protein and its dynamic behaviour as discussed in the text the other hand, has characteristics of an unfolded highly mobile peptide: intense peaks concentrated in a narrow range of 1 H frequencies. Finally, the spectrum of R337C re¯ects a protein that is not in a single conformation, but rather is an equilibrium mixture of two or more interconverting conformational states. These data are all consistent with the results of light scattering, crosslinking and CD measurements leading to the conclusion that L344P is completely defective for homo-oligomerization, while R337C is able to homooligomerize, although less eciently than WTp53 at ambient and physiological temperatures.
In order to determine how these oligomerization defects aect protein function we assayed two important biochemical activities of both mutants, hetero-oligomerization with WTp53 and sequencespeci®c DNA-binding. Figure 5 shows the results of mixing dierentially tagged constructs of WTp53 with R337C (Figure 5a ) or L344P ( Figure 5b ). As expected based on the biophysical analysis presented above, L344P can not hetero-oligomerize with WTp53, but R337C can. Similarly, in gel shift assays (Figure 6 ), L344P was unable to bind to a p53 consensus element while R337C was able to bind with similar anity to WTp53.
The biophysical and biochemical analysis presented here helps explain the observed phenotype of both mutants. The L344P mutation was ®rst observed in a yeast screen for functionally defective mutations in the C-terminus of p53 (Ishioka et al., 1995) . This mutant was unable to transactivate a reporter gene, cause cell cycle arrest in response to DNA damage or suppress growth (Ishioka et al., 1995) . These activities can all be explained by the fact that L344P cannot oligomerize and consequently has a much lower sequence-speci®c DNA binding anity. The fact that a L344P germline mutation has appeared in a family with Li ± Fraumeni syndrome (Varley et al., 1996) also suggests that this mutation is inactive in vivo. It was also reported that tumour tissue from the proband of this family had lost the WTp53 allele. This is consistent with the inability of L344P to interact with and inactivate WTp53 making loss of the WT allele necessary for tumour progression.
R337C has been reported as a sporadic mutation (Hollstein et al., 1996) and as a familial germline mutation in two families with Li ± Fraumeni-like syndrome (Lomax et al., 1997 ; S Verselis personal Figure 5 Assessment of hetero-oligomerization between WTp53 and R337C or WTp53 and L344P run on 15% SDSpolyacrylamide glycine or tricine gels, respectively. (a) Equimolar samples of (His) 6 -R337C(310 ± 393) (lane 1) and WTp53(310 ± 360) with no (His) 6 -tag (lane 2) were incubated at 378C overnight (lane 3) and loaded onto a 200 ml bed of QIAGEN Ni-NTA agarose beads, and subsequently washed (lanes 4 ± 8) with 3 ml of 30 mM imidazole, 500 mM NaCl, 40 mM Tris-HCl pH 7.5, and eluted (lanes 9 ± 12) with 2 ml of 500 mM imidazole, 500 mM NaCl, 40 mMTris-HCl pH 7.5. Degradation products of R337C which have lost the (His) 6 -tag are visible in the incubated mixture (lane 3) as well as the wash (lane 6). The presence of WTp53 in lanes 9 and 10 indicate that the two proteins are capable of hetero-oligomerization. (b) Equimolar samples of (His) 6 -L344P(310 ± 360) (lane 2) and WTp53(310 ± 360) with no (His) 6 -tag (lane 3) were incubated at 378C overnight (lane 4) and loaded onto a 200 ml bed of QIAGEN Ni-NTA agarose beads, and subsequently washed (lanes 5 ± 8) with 3 ml of 30 mM imidazole, 500 mM NaCl, 40 mM Tris-HCl pH 7.5 and eluted (lanes 9 ± 12) with 2 ml of 500 mM imidazole, 500 mM NaCl, 40 mM Tris-HCl pH 7.5). The absence of any WTp53 in the elution fractions indicates that there is no detectable hetero-oligomerization of WTp53 with L344P Figure 6 Gel mobility shift assay of full length recombinant WTp53 and mutants. Full length proteins were expressed and puri®ed as described by Vaziri et al. (1997) . In each case the indicated amount of protein was incubated with and without monoclonal antibody PAb421 which binds to the C-terminus of p53 and increases the anity of latent recombinant p53 for its consensus sequence (Hupp et al., 1992) . The palindromic p53 recognition sequence, 5'-GGACATGCCCGGGCATGTCC-3', was labelled with g-32 P-ATP with T4 DNA kinase, annealed and puri®ed according to Sambrook et al. (1989) . The indicated amounts of protein (®nal concentration) were mixed with 0.5 pmol of labelled probe (4000 ± 10 000 c.p.m.) in binding buer (20 mM HEPES-KOH (pH=7.9), 60 mM KCl, 0.2 mM EDTA, 6 mM MgCl 2 , 1 mM DTT and 10% glycerol) and incubated on ice for 5 min. A total of 0.3 mg of PAb421 was added to half the samples as indicated, and the mixtures incubated on ice for another 20 min. Samples were loaded onto a pre-equilibrated 0.256TBE 5% polyacrylamide gel and electrophoresed for 2 h at room temperature communication). In a yeast functional assay for transactivation that usually yields large white colonies for active p53 and small red colonies for inactive p53, R337C produced medium-sized pink colonies (Lomax et al., 1997) . Likewise in assays for the ability of p53 to trigger apoptosis (Lomax et al., 1997) , activate a reporter gene or suppress growth (Lomax et al., 1998) R337C had an activity intermediate between WT and completely inactive p53. Thus, in all in vivo assays R337C has an intermediate level of activity. Our data presented here oer an explanation for this lower level of activity. At physiological temperatures a much higher proportion of R337C appears to be in the monomeric and presumably inactive state. Our data also show that R337C can hetero-oligomerize with WTp53 which would lead to destabilized heterooligomers, although it is not clear to what extent this would eect the activity of the WT allele.
In summary, we show that the functional and biochemical defects in two familial germline mutations in the oligomerization domain of p53 correlate with defects in oligomerization. In the case of L344P, the monomeric mutant is completely inactive, and cannot interact with WTp53. R337C, on the other hand, can form homo-tetramers, however, at physiological temperatures only about half the protein is oligomeric. An additional consequence of defective oligomerization may be an alteration in the interactions of p53 with other cellular proteins. For example, Lomax et al. (1998) have shown that both L344P and R337C have reduced ability to bind to MDM2 which forms a negative feedback regulatory loop with p53. Other proteins such as tms1 (Wagner et al., 1995) and p34 cdc2 (Wagner et al., 1998) interact with residues in the tet domain spanning the R337C mutation site. The occurrence of these two mutations in familial cancers underlines the important role the tet domain plays in p53 function. The fact that R337C is only partially inactive suggests that any mutation in the oligomerization domain which gives rise to a signi®cant oligomerization defect can lead to tumour progression in the absence of the WT allele. The small number of tumour-derived and germline mutations in the tet domain identi®ed to date is likely the result of two factors. First the tet domain appears to be less sensitive to destabilization from individual point mutations compared to the DNA binding domain (Jerey et al., 1995; Waterman et al., 1995) . A second reason, however, is the fact that most researchers who screen for p53 mutations only screen the central DNA binding region. Thus, as pointed out previously (Casey et al., 1996; Lomax et al., 1997) there may be a higher proportion of cancer-related mutations in the tet domain (and other regions) of p53 than previously thought.
